A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care.

Clinical trial NCT04953052 · WITHDRAWN

Trial details

NCT number: NCT04953052
Sponsor: Exvastat Ltd.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome COVID-19 Acute Respiratory Distress Syndrome Covid19 ARDS Pulmonary Oedema

Start date: 2021-10-14
Primary completion: 2022-08-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.